<code id='0873E8ED5C'></code><style id='0873E8ED5C'></style>
    • <acronym id='0873E8ED5C'></acronym>
      <center id='0873E8ED5C'><center id='0873E8ED5C'><tfoot id='0873E8ED5C'></tfoot></center><abbr id='0873E8ED5C'><dir id='0873E8ED5C'><tfoot id='0873E8ED5C'></tfoot><noframes id='0873E8ED5C'>

    • <optgroup id='0873E8ED5C'><strike id='0873E8ED5C'><sup id='0873E8ED5C'></sup></strike><code id='0873E8ED5C'></code></optgroup>
        1. <b id='0873E8ED5C'><label id='0873E8ED5C'><select id='0873E8ED5C'><dt id='0873E8ED5C'><span id='0873E8ED5C'></span></dt></select></label></b><u id='0873E8ED5C'></u>
          <i id='0873E8ED5C'><strike id='0873E8ED5C'><tt id='0873E8ED5C'><pre id='0873E8ED5C'></pre></tt></strike></i>

          focus

          focus

          author:knowledge    Page View:15377
          Two researchers look at a computer monitor showing a graph and other data
          Adobe

          Research universities are voicing concerns over some proposed changes to the process for reviewing scientific misconduct allegations, citing worries that new government requirements would hobble their own independent procedures and constitute a huge administrative burden.

          Nearly two decades since it last released research misconduct rules, the U.S. Office of Research Integrity (ORI) is ready to update its requirements for ensuring the scientific standards of projects funded by the U.S. Department of Health and Human Services, including the National Institutes of Health.

          advertisement

          The proposed changes, published on Oct. 6, include a new formal process that institutions would follow in reviewing allegations, a 30-day deadline for institutions to assess allegations, and provisions that make it harder to quickly dismiss cases that institutions believe to be “honest errors.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          How to keep neuroscience’s past racism from being its future
          How to keep neuroscience’s past racism from being its future

          De-ShaineMurrayisworkingatthecuttingedgeofneurotechnology.AsapostdoctoralfellowatYale,heisdeveloping

          read more
          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more

          David Ricks of Eli Lilly: best biopharma CEO of 2023

          HyacinthEmpinado/STATIt’sthattimeoftheyearagainwhenIrecognizetheBestBiopharmaCEOoftheyear.Thisyear’s